Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (18)

2024

  1. COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES

    European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

2022

  1. Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer

    Oral Oncology, Vol. 134

  2. Severe Hyponatremia Masking Central Diabetes Insipidus in a Patient with a Lung Adenocarcinoma

    Case Reports in Oncology, Vol. 15, Núm. 1, pp. 91-98

2021

  1. EXPRESIÓN DE LA PROTEÍNA P53 POR INMUNOHISTOQUÍMICA COMO BIOMARCADOR PREDICTIVO DE RESPUESTA A INMUNOTERAPIA EN CÁNCER DE PULMÓN NO MICROCÍTICO CON ALTA EXPRESIÓN DE PDL1

    SEOM 2021 VIRTUAL

  2. Head and neck cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1393-1401

  3. Immunotherapy in lung cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1424-1428

  4. Mesothelioma

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1402-1408

  5. Molecular and cellular biomarkers. Implications for targeted therapy

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1418-1423

  6. Non-small cell lung cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1377-1387

  7. Paciente gran superviviente con cáncer de cabeza y cuello metastásico y tratamiento con inmunoterapia

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1429.e1-1429.e3

  8. Small cell lung cancer

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1369-1376

  9. Therapeutic and palliative indications of radiotherapy in lung and thoracic tumors

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1409-1413

  10. Therapeutic and palliative indications of surgery in lung and thoracic tumors

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1414-1417

  11. Thymic epithelial tumors. Thymoma

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1388-1392

2020

  1. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations

    Biomedicine and Pharmacotherapy, Vol. 121